spacer
The Healthcare Sales & Marketing Network celebrates 26 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  postoperative ileus 

 HSMN NewsFeed - 1 Mar 2016
Leading BioSciences Expands Executive Leadership Team, Appoints Dr. Howard Dittrich as Chief Medical Advisor and Stephen Keane as Senior Vice President of Corporate Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 18 Oct 2011
Tranzyme Pharma Names Former Gilead Executive Franck Rousseau, M.D. Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 16 Jun 2010
Tranzyme Pharma and Norgine Sign License Agreement for Late-Stage Development Product, Ulimorelin (TZP-101), in Europe and Other Select Regions
Biopharmaceuticals Licensing
 HSMN NewsFeed - 17 May 2010
Tranzyme Pharma Presents Data Demonstrating that TZP-101 (Ulimorelin) Restores Bowel Function in Patients with Postoperative Ileus (POI) Regardless of the Extent of Opioid Use
Biopharmaceuticals
 HSMN NewsFeed - 2 Sep 2008
Adolor Regains Rights to Entereg(R) (alvimopan) for OBD
Biopharmaceuticals
 HSMN NewsFeed - 3 Jul 2008
Adolor Provides Update on Entereg(R) (alvimopan) OBD Program
Biopharmaceuticals FDA
 HSMN NewsFeed - 28 May 2008
New England Journal of Medicine Publishes Results From a RELISTOR Phase 3 Clinical Study
Biopharmaceuticals
 HSMN NewsFeed - 20 May 2008
Adolor and GlaxoSmithKline Announce FDA Approval of Entereg(R) (alvimopan) for the Management of Postoperative Ileus (POI)
Biopharmaceuticals FDA
 HSMN NewsFeed - 9 May 2008
Adolor Provides Regulatory Update on Entereg(R) (alvimopan)
Biopharmaceuticals
 HSMN NewsFeed - 24 Apr 2008
Wyeth and Progenics Receive Positive Opinion From European Committee for RELISTOR for the Treatment of Opioid-Induced Constipation in Advanced-Illness Patients
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 1 Apr 2008
Wyeth and Progenics Announce RELISTOR Receives Canadian Marketing Approval
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 12 Mar 2008
Wyeth and Progenics Provide Update on Phase 3 Clinical Trial of Intravenous Methylnaltrexone for Postoperative Ileus
Biopharmaceuticals
 HSMN NewsFeed - 8 Feb 2008
FDA Extends Review of NDA for ENTEREG(R) (alvimopan)
Biopharmaceuticals FDA
 HSMN NewsFeed - 23 Jan 2008
Adolor and GlaxoSmithKline Report Favorable FDA Advisory Committee Meeting for ENTEREG(R) (alvimopan) for the Management of Postoperative Ileus in Bowel Resection
Biopharmaceuticals
 HSMN NewsFeed - 28 Nov 2007
Adolor and GlaxoSmithKline Announce FDA Advisory Committee to Review Entereg(R) (alvimopan) for the Management of Postoperative Ileus (POI)
Biopharmaceuticals Surgery
 HSMN NewsFeed - 7 Nov 2007
Axiom Worldwide's International Medical Advisory Board Steering Committee Issues Consensus Statement Regarding the Axiom Protocols!
Devices Neurosurgery Orthopaedic
 HSMN NewsFeed - 13 Sep 2007
FDA To Continue Its Review of Requests for Release of Clinical Hold on alvimopan (Entereg(R))
Biopharmaceuticals FDA
 HSMN NewsFeed - 28 Aug 2007
FDA Accepts for Review Complete Response to Approvable Letter for Entereg(R) (alvimopan) for POI
Biopharmaceuticals Surgery FDA
 HSMN NewsFeed - 11 Jun 2007
GSK and Adolor Update Alvimopan (Entereg/Entrareg(R)) Development Program
Biopharmaceuticals
 HSMN NewsFeed - 14 Dec 2006
Adolor Elects Michael R. Dougherty Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Dec 2006
Adolor Announces Discontinuation of Sales Force and Other Selected Work Force Reductions
Biopharmaceuticals
 HSMN NewsFeed - 7 Nov 2006
Alliance Pharmaceutical Corp. Provides Clinical Study Update
Biopharmaceuticals Surgery
 HSMN NewsFeed - 6 Nov 2006
FDA Issues Approvable Letter for Entereg(R) (alvimopan) for POI
Biopharmaceuticals FDA
 HSMN NewsFeed - 19 Sep 2006
Sapphire Therapeutics, Inc. Licenses Ghrelin Mimetic From Novo Nordisk
Biopharmaceuticals Gastroenterology Surgery Licensing
 HSMN NewsFeed - 17 Jul 2006
Wyeth and Progenics Announce Methylnaltrexone Receives FDA Fast Track Designation for Treatment of Postoperative Ileus
Biopharmaceuticals FDA
 HSMN NewsFeed - 31 May 2006
Adolor's Complete Response to Approvable Letter for Entereg(R) (Alvimopan) in POI Accepted for Review by FDA
Biopharmaceuticals Gastroenterology Surgery FDA
 HSMN NewsFeed - 4 May 2006
GlaxoSmithKline and Adolor Present Positive Results from a Clinical Study of Alvimopan (Entereg(R))
Biopharmaceuticals
Return to NewsFeed  

 Additional items found! 28

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 28 additional stories matching:
postoperative ileus
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.